Our Access Strategy for LMIC service helps pharmaceutical companies design and implement access strategies for low- and middle-income countries. We develop tiered pricing models, voluntary licensing strategies, and access programs that balance patient access with commercial sustainability. Our approach supports global health equity while maintaining business viability.
How our access strategy for lmic service delivers value to your organization.
Tiered pricing model design based on country income level, disease burden, and ability to pay.
Voluntary licensing strategy including patent pool participation and generic partner selection.
Patient access program design including donation programs, tiered access, and capability building.
Access impact measurement framework tracking patient reach, health outcomes, and sustainability.
Comprehensive deliverables that provide actionable intelligence for your team.
A structured methodology that delivers results in four phases.
Assess LMIC markets including disease burden, health system capacity, and ability to pay.
Design access strategy including pricing, licensing, and programs.
Engage governments, NGOs, and global health organizations in access strategy.
Support implementation including program launch, monitoring, and adaptation.
Tiered pricing is a strategy where pharmaceutical companies charge different prices in different countries based on income level, disease burden, and ability to pay, ensuring affordability while maintaining revenue from higher-income markets.
We design tiered pricing strategies with safeguards against parallel trade including contract restrictions, packaging differentiation, supply monitoring, and regulatory engagement.
Yes, we support engagement with patent pools like MPP (Medicines Patent Pool) including license negotiation, scope definition, and generic partner selection.
Connect with our team to discuss how our access strategy for lmic service can support your goals.
Schedule a Consultation